BDR Pharma will acquire a controlling stake in the oral solid formulations business of Acme Formulation Private Limited and its subsidiaries from existing shareholders, including PAG. In a separate development, Arka Fincap Ltd, a non-banking financial company (NBFC), has signed definitive agreements with The Rise Funds, TPG’s global impact investing platform.
BDR Pharma to buy Acme’s oral solid formulations biz
BDR Pharma will acquire a controlling stake in the oral solid formulations business of Acme Formulation Private Limited and its subsidiaries from its existing shareholder PAG, among others.
According to a press statement, the acquisition fits BDR’s growth plans in oncology, critical care and women’s healthcare. It will also help the company expand its product range in international markets.
The acquisition will add to BDR’s existing capabilities in thyroid products, female sex hormones and general pharmaceutical products.
“We have been on a strong growth trajectory driven by strategic investments, innovation and an expanding global ambition. Acme will further strengthen our CDMO platform and add differentiated capabilities,” said Dharmesh Shah, chairman and managing director of BDR Pharma.
o3 Capital acted as the exclusive financial advisor to BDR Pharma on the transaction.
Founded in 2003, BDR Pharma makes and sells generic medicines, with a focus on oncology, women’s healthcare and critical care. It is also expanding into other specialised areas.
Meanwhile, Acme Formulation provides contract manufacturing and R&D services to Indian and global pharma companies. It specialises in hormone, thyroid and other complex oral medicines, and exports to over 40 countries.
Kirloskar-backed Arka Fincap raises funding from TPG
Arka Fincap Ltd, a non-banking financial company (NBFC) headquartered in Mumbai, has signed definitive agreements with The Rise Funds, TPG’s global impact investing platform, per an announcement.
The investment includes an initial commitment of Rs 525 crore, with the possibility of a further Rs 275 crore in a second tranche, subject to meeting specified business milestones and regulatory approvals.
Promoted by the Kirloskar Group, Arka was established in 2018. It currently has assets under management (AUM) of Rs 8,000 crore and operates across 10 states.
The funding will help the company expand its lending business, reach more customers across geographies, invest in technology and strengthen its risk management capabilities.
“Many of India’s MSMEs and vehicle operators remain underserved by formal financial services, and Arka has built a disciplined, secured retail lending platform to serve these customers, with the potential to reach even more customers at scale,” said Simit Batra, BU Partner, TPG.
Avendus Capital acted as the exclusive financial advisor on the transaction.
